The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Derangement of immune responses by myeloid suppressor cells
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., & Schadendorf, D. (1998) · Nature Medicine · doi:10.1038/nm0398-328 · Cited by 2,862
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology
Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A., O'Garra, A., Biron, C., Brière, F., et al. (2001) · Nature Immunology · doi:10.1038/ni736 · Cited by 1,022
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., & Rollins, B. J. (2000) · Nature · doi:10.1038/35006097 · Cited by 832
NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway
Terabe, M., Matsui, S., Noben-Trauth, N., Chen, H., Watson, C., Donaldson, D. D., Carbone, D. P., Paul, W. E., & Berzofsky, J. A. (2000) · Nature Immunology · doi:10.1038/82771 · Cited by 699
Clinical significance of defective dendritic cell differentiation in cancer.
Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Self-citationFleming, T. J., Fleming, M. L., & Malek, T. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2399 · Cited by 619
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M., & Zanovello, P. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00132-7 · Cited by 592
Self-citationMechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., & Zanovello, P. (2000) · Blood · doi:10.1182/blood.v96.12.3838 · Cited by 527
Self-citationIL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.270 · Cited by 513
Self-citationRegulation of T Cell Receptor CD3ζ Chain Expression byl-Arginine
Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B., & Ochoa, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110675200 · Cited by 509
Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., & Restifo, N. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5728 · Cited by 405
Self-citationO'Keeffe, M., Hochrein, H., Vremec, D., Caminschi, I., Miller, J. L., Anders, E. M., Wu, L., Lahoud, M. H., Henri, S., Scott, B., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021031 · Cited by 368
Kono, K., Salazar‐Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., & Kiessling, R. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260620 · Cited by 359
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Flow cytometric identification of murine neutrophils and monocytes
Lagasse, E., & Weissman, I. L. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00138-x · Cited by 338
Strategies for designing and optimizing new generation vaccines
Berzofsky, J. A., Ahlers, J. D., & Belyakov, I. M. (2001) · Nature Reviews Immunology · doi:10.1038/35105075 · Cited by 334
Markers of mouse macrophage development detected by monoclonal antibodies
Leenen, P. J. M., de Bruijn, M. F. T. R., Voerman, J. S. A., Campbell, P. A., & van Ewijk, W. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90005-1 · Cited by 333
Blocking NO synthesis: how, where and why?
Vallance, P., & Leiper, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd960 · Cited by 331
Tatsumi, T., Kierstead, L. S., Ranieri, E., Gesualdo, L., Schena, F. P., Finke, J. H., Bukowski, R. M., Mueller-Berghaus, J., Kirkwood, J. M., Kwok, W. W., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012142 · Cited by 314
Bronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A., & Restifo, N. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5313 · Cited by 312
Self-citationBrito, C., Naviliat, M., Tiscornia, A. C., Vuillier, F., Gualco, G., Dighiero, G., Radi, R., & Cayota, A. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3356 · Cited by 306
Immature myeloid cells and cancer-associated immune suppression
Kusmartsev, S., & Gabrilovich, D. I. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297
Melani, C., Chiodoni, C., Forni, G., & Colombo, M. P. (2003) · Blood · doi:10.1182/blood-2003-01-0190 · Cited by 295
Chang, C., Liao, J. C., & Kuo, L. (2001) · PubMed · Cited by 294
Lee, K.-H., Wang, E., Nielsen, M.-B., Wunderlich, J., Migueles, S., Connors, M., Steinberg, S. M., Rosenberg, S. A., & Marincola, F. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6292 · Cited by 285
Pak, A. S., Wright, M. A., Matthews, J. P., Collins, S. L., Petruzzelli, G. J., & Young, M. R. I. (1995) · PubMed · Cited by 271
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250
Self-citationKorsgren, M., Persson, C. G. A., Sundler, F., Bjerke, T., Hansson, T., Chambers, B. J., Hong, S., Van Kaer, L., Ljunggren, H.-G., & Korsgren, O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.553 · Cited by 246
Tumor-induced immune dysfunction
Kiessling, R., Wasserman, K., Horiguchi, S., Kono, K., Sjöberg, J., Pisa, P., & Petersson, M. (1999) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050586 · Cited by 237
Strober, S. (1984) · Annual Review of Immunology · doi:10.1146/annurev.iy.02.040184.001251 · Cited by 222
NKT cells and tumor immunity—a double-edged sword
Smyth, M. J., & Godfrey, D. I. (2000) · Nature Immunology · doi:10.1038/82698 · Cited by 209
Seo, N., Hayakawa, S., Takigawa, M., & Tokura, Y. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01279.x · Cited by 206
Macrophage arginine metabolism and the inhibition or stimulation of cancer
Mills, C. D., Shearer, J., Evans, R., & Caldwell, M. D. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2709 · Cited by 191
Anichini, A., Molla, A., Mortarini, R., Tragni, G., Bersani, I., Di Nicola, M., Gianni, A. M., Pilotti, S., Dunbar, R., Cerundolo, V., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.651 · Cited by 190
Goni, O., Alcaide, P., & Fresno, M. (2002) · International Immunology · doi:10.1093/intimm/dxf076 · Cited by 179
Kobayashi, M., Kobayashi, H., Pollard, R. B., & Suzuki, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5869 · Cited by 171
Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.
Seung, L. P., Rowley, D. A., Dubey, P., & Schreiber, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6254 · Cited by 170
Terrazas, L. I., Walsh, K. L., Piskorska, D., McGuire, E., & Harn, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5294 · Cited by 169
Angulo, I., de las Heras, F. G., Garcı́a-Bustos, J. F., Gargallo, D., Muñoz-Fernández, M. A., & Fresno, M. (2000) · Blood · doi:10.1182/blood.v95.1.212 · Cited by 161
Young, M. R. I., Wright, M. A., Lozano, Y., Prechel, M. M., Benefield, J., Leonetti, J. P., Collins, S. L., & Petruzzelli, G. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<69::aid-ijc12>3.0.co;2-d · Cited by 160
Saio, M., Radoja, S., Marino, M., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5583 · Cited by 157
Immortalized Myeloid Suppressor Cells Trigger Apoptosis in Antigen-Activated T Lymphocytes
Apolloni, E., Bronte, V., Mazzoni, A., Serafini, P., Cabrelle, A., Segal, D. M., Young, H. A., & Zanovello, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6723 · Cited by 157
Self-citationEffects of L‐Arginine on the Proliferation of T Lymphocyte Subpopulations
Ochoa, J. B., Strange, J., Kearney, P. A., Gellin, G. L., Endean, E. D., & Fitzpatrick, E. A. (2001) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860710102500123 · Cited by 152
Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity
Salvadori, S., Martinelli, G. P., & Zier, K. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2214 · Cited by 144
Young, M. R., Wright, M. A., Matthews, J. P., Malik, I., & Prechel, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1916 · Cited by 142
CD80+Gr-1+ Myeloid Cells Inhibit Development of Antifungal Th1 Immunity in Mice with Candidiasis
Mencacci, A., Montagnoli, C., Bacci, A., Cenci, E., Pitzurra, L., Spreca, A., Köpf, M., Sharpe, A. H., & Romani, L. R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3180 · Cited by 139
Koblish, H. K., Hunter, C. A., Wysocka, M., Trinchieri, G., & Lee, W. M. F. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1603 · Cited by 122
de Jonge, W. J., Kwikkers, K. L., Velde, A. A. T., van Deventer, S. J. H., Nolte, M. A., Mebius, R. E., Ruijter, J. M., Lamers, M. C., & Lamers, W. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16143 · Cited by 113
Classical and Slow-Binding Inhibitors of Human Type II Arginase
Colleluori, D. M., & Ash, D. E. (2001) · Biochemistry · doi:10.1021/bi010783g · Cited by 111
Uses of granulocyte-macrophage colony-stimulating factor in vaccine development
Warren, T. L., & Weiner, G. J. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200005000-00007 · Cited by 110
Clinical significance of the determination of angiogenic factors
Toi, M., Taniguchi, T., Yamamoto, Y., Kurisaki, T., Suzuki, H., & Tominaga, T. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00397-8 · Cited by 107
Role of Ornithine as a Proline Precursor in Healing Wounds
Albina, J. E., Abate, J. A., & Mastrofrancesco, B. (1993) · Journal of Surgical Research · doi:10.1006/jsre.1993.1114 · Cited by 105
Liu, Y., Ginderachter, J. A. V., Brys, L., BAETSELIER, P. D., Raes, G., & Geldhof, A. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5064 · Cited by 104
de Jonge, W. J., Kwikkers, K. L., Velde, A. A. T., van Deventer, S. J. H., Nolte, M. A., Mebius, R. E., Ruijter, J. M., Lamers, M. C., & Lamers, W. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216143 · Cited by 103
Peláez, B., Campillo, J. A., García‐Asenjo, J. A. L., & Subiza, J. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6608 · Cited by 93
Membrane Molecules as Differentiation Antigens of Murine Macrophages
McKnight, A. J., & Gordon, S. (1998) · Advances in immunology · doi:10.1016/s0065-2776(08)60562-3 · Cited by 89
Mice Bearing Late-Stage Tumors Have Normal Functional Systemic T Cell Responses In Vitro and In Vivo
Radoja, S., Rao, T. D., Hillman, D., & Frey, A. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2619 · Cited by 88
Ahlers, J. D., Belyakov, I. M., Terabe, M., Koka, R., Donaldson, D. D., Thomas, E. K., & Berzofsky, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192251199 · Cited by 88
Superantigen-Induced CD4 T Cell Tolerance Mediated by Myeloid Cells and IFN-γ
Cauley, L. S., Miller, E., Yen, M., & Swain, S. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6056 · Cited by 87
Development of splenic natural suppressor (NS) cells in ehrlich tumor‐bearing mice
Subiza, J. L., Viñuela, J. E., Rodríguez, R., Gil, J., Figueredo, M. A., & de la Concha, E. G. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440220 · Cited by 80
Regulation of adaptive immunity by natural killer cells
Kos, F. J. (1998) · Immunologic Research · doi:10.1007/bf02786453 · Cited by 69
Billiau, A., Fevery, S., Rutgeerts, O., Landuyt, W., & Waer, M. (2003) · Blood · doi:10.1182/blood-2002-06-1833 · Cited by 68
Horiguchi, S., Petersson, M., Nakazawa, T., Kanda, M., Zea, A. H., Ochoa, A. C., & Kiessling, R. W. (1999) · PubMed · Cited by 66
Pericle, F., Kirken, R. A., Bronte, V., Sconocchia, G., DaSilva, L., & Segal, D. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.6.2580 · Cited by 54
Self-citationNitric Oxide Mediation of Active Immunosuppression Associated With Graft-Versus-Host Reaction
Bobé, P., Benihoud, K., Grandjon, D., Opolon, P., Pritchard, L. L., & Huchet, R. (1999) · Blood · doi:10.1182/blood.v94.3.1028.415k24_1028_1037 · Cited by 51
Geldhof, A. B., Ginderachter, J. A. V., Liu, Y., Noël, W., Raes, G., & BAETSELIER, P. D. (2002) · Blood · doi:10.1182/blood-2001-11-0106 · Cited by 48
Pillars Article: M-1/M-2 Macrophages and the Th1/Th2 Paradigm. J. Immunol. 2000. 164: 6166–6173
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701141 · Cited by 48
Angulo, I., Rullás, J., Campillo, J. A., Obregón, E., Heath, A. W., Howard, M., Muñoz‐Fernández, M. Á., & Subiza, J. L. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200005)30:5<1263::aid-immu1263>3.0.co;2-5 · Cited by 47
Melanoma vaccines: the paradox of T cell activation without clinical response
Nielsen, M.-B., & Marincola, F. M. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/pl00014052 · Cited by 45
Marshall, M. A., Jankovic, D. L., Maher, V. E., Sher, A., & Berzofsky, J. A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01499-x · Cited by 32
Maier, T., Holda, J. H., & Hn, C. (1989) · PubMed · Cited by 32
Cited by
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Self-citationHuang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., & Albelda, S. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0883 · Cited by 1,054
Metadata
- Authors
- Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P., & Bronte, V.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2003-10-30
- Volume
- 53
- Issue
- 2
- Pages
- 64-72
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W2067971586
- Cited by
- 335
- References
- 78
- FWCI
- 7.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.